InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,346.56
(
-1.84%
)
US TECH 100
17,900.00
(
-2.65%
)
Dow Jones
39,737.26
(
-1.51%
)
Brent Oil
77.36
(
0.00%
)
Bitcoin
60,594.69
(
-1.35%
)
Post# of 252781
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

rfj1862

Send PM Follow Ignore
Followers 39
Posts 1714
Boards Moderated 0
Alias Born 10/05/2005

rfj1862

Re: None

Monday, 06/11/2007 8:13:27 PM

Monday, June 11, 2007 8:13:27 PM

Post# of 252781
RPRX--Dow Jones

Where do they get these idiots?

Repros Therapeutics Inc. (RPRX) said a six-month study of Proellex showed the drug reduced the duration and intensity of pain more effectively than Lucrin when treating endometriosis.

The Woodlands, Texas, pharmaceutical company said it plans to start a Phase II clinical trial of the drug by the end of the year.

Repros's shares closed Monday down 37 cents, or 2.5%, $14.93.

-Andrew Edwards; 201-938-5400; AskNewswires@dowjones.com
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up